Literature DB >> 29970126

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Qian Huang¹, Jiajia Xi¹, Lei Wang^1,2, Xu Wang¹, Xiaodong Ma^1,2, Qipan Deng¹, Yong Lu¹, Munish Kumar^1,3, Zhiyuan Zhou^1,4, Ling Li⁴, Zhaoyang Zeng⁵, Ken H Young⁶, Qing Yi¹, Mingzhi Zhang⁴, Yong Li⁷.

Abstract

The original article [1] contains a spelling error in the authorship; the authors would like to note the correct spelling of the second author, Jiajia Xi.

Entities: Chemical Gene

Year: 2018 PMID： 29970126 PMCID： PMC6030738 DOI： 10.1186/s13045-018-0633-1

Source DB: PubMed Journal: J Hematol Oncol ISSN： 1756-8722 Impact factor: 17.388

Correction

The original article [1] contains a spelling error in the authorship; the authors would like to note the correct spelling of the second author, Jiajia Xi.

1 in total

1. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Authors: Qian Huang; Jiajia Xia; Lei Wang; Xu Wang; Xiaodong Ma; Qipan Deng; Yong Lu; Munish Kumar; Zhiyuan Zhou; Ling Li; Zhaoyang Zeng; Ken H Young; Qing Yi; Mingzhi Zhang; Yong Li
Journal: J Hematol Oncol Date: 2018-04-23 Impact factor: 17.388

1 in total

4 in total

Review 1. Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress.

Authors: Juanjuan Zhao; Meirong Wu; Zhifeng Li; Sheng Su; Yin Wen; Litian Zhang; Yuhua Li
Journal: Ann Hematol Date: 2020-05-09 Impact factor: 3.673

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Correction

1. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.

Review 1. Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress.

Review 2. Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer.

Review 3. Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells.

4. MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1.